Skip to main content
NCBI home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1977 Nov;29(6):581–592.

Detection of genetic variation with radioactive ligands. I. Electrophoretic screening of plasma proteins with a selected panel of compounds.

L L Cavalli-Sforza, S P Daiger, D P Rummel
PMCID: PMC1685497  PMID: 930924

Abstract

To detect new genetic variation in human plasma proteins, a panel of 63 radioactive substances were screened as potential radioligands using polyacrylamide gel electrophoresis (PAGE) and autoradiography. Vitamins, hormones, drugs, amino acids, purines, pyrimidines, sugars and lipids labeled with 14C or other radionuclides were among those substances tested. A majority bound to albumin and a smaller fraction to prealbumins and lipoproteins. Several vitamins and hormones bound to specific alpha and beta globulins. (1) Electrophoretic polymorphisms of vitamin D-binding protein (group-specific component), a vitamin B12-binding protein (transcobalamin II), and thyroxine-binding alpha-globulin are described elsewhere. (2) Testosterone-binding beta-globulin (TeBG) showed an electrophoretic polymorphism in Caucasians and a possible deficiency allele. (3) Transcortin showed an electrophoretic doublet in all persons tested but no electrophoretic variation. (4) A protein binding derivative of norepinephrine or epinephrine was identified as transferrin. (5) A nonpolymorphic protein running cathodal to albumin and binding a derivative of riboflavin was tentatively identified as a fraction of albumin with mobility altered as a result of interaction with the ligand.

Full text

PDF
581

Images in this article

584Fig. 1
on p.584
585Fig. 2
on p.585
587Fig. 3
on p.587
589Fig. 4
on p.589

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corvol P. L., Chrambach A., Rodbard D., Bardin C. W. Physical properties and binding capacity of testosterone-estradiol-binding globulin in human plasma, determined by polyacrylamide gel electrophoresis. J Biol Chem. 1971 Jun 10;246(11):3435–3443. [PubMed] [Google Scholar]
  2. Daiger S. P., Cavalli-Sforza L. L. Detection of genetic variation with radioactive ligands. II. Genetic variants of vitamin D-labeled group-specific component (Gc) proteins. Am J Hum Genet. 1977 Nov;29(6):593–604. [PMC free article] [PubMed] [Google Scholar]
  3. Daiger S. P., Schanfield M. S., Cavalli-Sforza L. L. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A. 1975 Jun;72(6):2076–2080. doi: 10.1073/pnas.72.6.2076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fagerhol M. K., Braend M. Classification of human serum prealbumins after starch gel electrophoresis. Acta Pathol Microbiol Scand. 1966;68(3):434–438. doi: 10.1111/apm.1966.68.3.434. [DOI] [PubMed] [Google Scholar]
  5. Fairbanks G., Jr, Levinthal C., Reeder R. H. Analysis of C14-labeled proteins by disc electrophoresis. Biochem Biophys Res Commun. 1965 Aug 16;20(4):393–399. doi: 10.1016/0006-291x(65)90589-9. [DOI] [PubMed] [Google Scholar]
  6. Harris H., Hopkinson D. A. Average heterozygosity per locus in man: an estimate based on the incidence of enzyme polymorphisms. Ann Hum Genet. 1972 Jul;36(1):9–20. doi: 10.1111/j.1469-1809.1972.tb00578.x. [DOI] [PubMed] [Google Scholar]
  7. Jusko W. J., Levy G. Plasma protein binding of riboflavin and riboflavin-5'-phosphate in man. J Pharm Sci. 1969 Jan;58(1):58–62. doi: 10.1002/jps.2600580110. [DOI] [PubMed] [Google Scholar]
  8. Koch-Weser J., Sellers E. M. Drug therapy. Binding of drugs to serum albumin (second of two parts). N Engl J Med. 1976 Mar 4;294(10):526–531. doi: 10.1056/NEJM197603042941005. [DOI] [PubMed] [Google Scholar]
  9. Pignatti P. F., Cavalli-Sforza L. L. Serotonin binding proteins from human blood platelets. An experimental model system for studies on properties of synaptic vesicles. Neurobiology. 1975 Mar;5(1):65–74. [PubMed] [Google Scholar]
  10. Powis G. The binding of catecholamines to human serum proteins. Biochem Pharmacol. 1975 Mar 15;24(6):707–712. doi: 10.1016/0006-2952(75)90247-6. [DOI] [PubMed] [Google Scholar]
  11. Richardson K. S., Nowaczynski W., Genest J. Letter: Aldosterone-binding proteins in human plasma. N Engl J Med. 1976 Jul 8;295(2):114–114. doi: 10.1056/NEJM197607082950228. [DOI] [PubMed] [Google Scholar]
  12. Scanu A. M., Wisdom C. Serum lipoproteins structure and function. Annu Rev Biochem. 1972;41:703–730. doi: 10.1146/annurev.bi.41.070172.003415. [DOI] [PubMed] [Google Scholar]
  13. Tulchinsky D., Chopra I. J. Competitive ligand-binding assay for measurement of sex hormone-binding globulin (SHBG). J Clin Endocrinol Metab. 1973 Dec;37(6):873–881. doi: 10.1210/jcem-37-6-873. [DOI] [PubMed] [Google Scholar]
  14. Waxman S., Schreiber C. Measurement of serum folate levels and serum folic acid-binding protein by 3H-PGA radioassay. Blood. 1973 Aug;42(2):281–290. [PubMed] [Google Scholar]
  15. Weitkamp L. R., Salzano F. M., Neel J. V., Porta F., Geerdink R. A., Tárnoky A. L. Human serum albumin: twenty-three genetic variants and their population distribution. Ann Hum Genet. 1973 Apr;36(4):381–392. doi: 10.1111/j.1469-1809.1973.tb00602.x. [DOI] [PubMed] [Google Scholar]
  16. Wilding G., Blumberg E. S., Vesell E. S. Reduced warfarin binding of albumin variants. Science. 1977 Mar 11;195(4282):991–994. doi: 10.1126/science.841323. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES